The label was changed after the company received reports of serious medical events, including death, after the steroid was injected into the epidural space near the spine. Kenalog and Pfizer drug Depo-Medrol are the most frequently used steroids for epidural injections. The procedure is common, and more than eight million such injections were given in the U.S. in 2010.
Physicians who spoke to Bloomberg said the warning is either being ignored by physicians or they aren’t aware of it. The report said Bristol-Myers and the FDA are not required to publicize the revision, and no announcement was made.
Sign up for our FREE Pain E-Weekly for more coverage like this sent to your inbox!
Related Articles on Pain Management:
Study Claims Neuropathy Patients More Likely to Receive High-Cost, Low-Yield Screening Instead of More Effective Tests
CAPS Paincare Opens Pain Management Clinic and Surgical Facility in Illinois
5 Ways to Boost Collections at Pain Management Centers
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
